StockSelector.com
  Research, Select, & Monitor Sunday, October 20, 2019 9:32:03 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Athersys Inc$1.34($.04)(2.90%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Athersys Inc vs Chemicals - Major Diversified

Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company's lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the treatment of obesity. The company is also developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). Athersys is developing MultiStem(r), its patented, adult-derived ``off the shelf'' stem cell product platform, for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications.




Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $24.3 Mil $229,028.6 Mil
  Market Cap: $201.2 Mil $259,184.6 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 554.7% 17.2%
  Estimated Revenue: (64.1%) (15.6%)
  Historic Earnings: N/A 15.2%
  Estimated Earnings: N/A 9.4%
  Stock Price (1 Year): (36.2%) (7.2%)
  Cash per Share: 45.6% 4.4%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 15.3
  Price-to-Sales: 21.1 N/A
  Price-to-Book: 4.4 2.5
  Dividend Yield: N/A N/A
  Market Cap: $201.2 Mil $28,798.3 Mil
  Operations
  Net Margin: (458.0%) 17.3%
  Gross Margin: 100.0% 34.4%
  Return on Equity: (.6) .2
  Return on Assets: (.4) .1
  Balance Sheet
  Current Ratio: 3.7 1.8
  Quick Ratio: 3.7 1.3
  Cash Ratio: 3.3 .4
  Debt-to-Equity: .4 1.6
  Interest Coverage: N/A .5
 Technicals
  Relative-Strength Index: 43.5 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $26.23 $61,809.4 Mil
  E.I. Du Pont De Nemours & Co., Inc.  (DD) $65.53 $49,082.0 Mil
  Air Products & Chemicals, Inc.  (APD) $214.88 $47,351.0 Mil
  Henkel KGaA  (HENKY) $23.63 $40,909.4 Mil
  Akzo Nobel N.V.  (AKZOY) $31.23 $21,360.4 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.